Reported Earlier, Gain Therapeutics Prices $11M Public Offering Of 7,116,547 Common Shares At $1.35/Share And Pre-Funded
Portfolio Pulse from Benzinga Newsdesk
Gain Therapeutics has announced the pricing of an $11 million public offering, which includes 7,116,547 shares of common stock at $1.35 per share and pre-funded warrants for 1,031,602 shares. The pre-funded warrants are immediately exercisable.
June 14, 2024 | 6:25 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Gain Therapeutics has priced an $11 million public offering, including 7,116,547 shares at $1.35 per share and pre-funded warrants for 1,031,602 shares. This move is likely to impact the stock price in the short term.
The issuance of new shares and pre-funded warrants typically dilutes existing shareholders' equity, which can lead to a short-term decrease in stock price. The offering price of $1.35 per share may also set a new benchmark for the stock's value.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100